PLASMA-ALDOSTERONE RESPONSE TO UPRIGHT POSTURE AND ANGIOTENSIN-II INFUSION IN ALDOSTERONE-PRODUCING ADENOMA

被引:44
作者
NOMURA, K [1 ]
TORAYA, S [1 ]
HORIBA, N [1 ]
UJIHARA, M [1 ]
AIBA, M [1 ]
DEMURA, H [1 ]
机构
[1] TOKYO WOMENS MED COLL, DIV SURG PATHOL, TOKYO 162, JAPAN
关键词
D O I
10.1210/jc.75.1.323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nineteen patients with primary aldosteronism due to surgically confirmed aldosterone-producing adenoma (APA) were examined to evaluate the response of aldosterone to upright Posture and angiotensin II infusion. Upright posture reportedly decreases the plasma aldosterone concentration (PAC) in APA but raises it in idiopathic hyperaldosteronism. However, our findings showed the opposite result, in that the upright posture did not change or raised PAC in 15 of 19 cases (79%). Angiotensin II was infused iv at doses from 0.5-2 ng/min-kg body weight in six patients in whom the upright posture raised PAC, but did not raise PAC in all cases. This result supports the assumption that APA is functionally insensitive to angiotensin II. A concomitant rise of ACTH, pretreatment with calcium channel blockade, and other modulating factors may be involved in this PAC rise. Whatever the reason, such a high frequency of patients with increased PAC in APA raises some question about the clinical value of the upright posture test. We believe, then, there is reason to check any interpretation concerning increased PAC in the case of the upright posture test in distinguishing between APA and idiopathic hyperaldosteronism.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 32 条
[1]  
ADAMSON U, 1980, ACTA MED SCAND, V208, P101
[2]  
AIBA M, 1981, AM J PATHOL, V103, P404
[3]   PRIMARY ADRENAL-HYPERPLASIA - A NEW SUBSET OF PRIMARY HYPER-ALDOSTERONISM [J].
BANKS, WA ;
KASTIN, AJ ;
BIGLIERI, EG ;
RUIZ, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (05) :783-785
[4]   IDENTIFICATION AND IMPLICATIONS OF NEW TYPES OF MINERALOCORTICOID HYPERTENSION [J].
BIGLIERI, EG ;
IRONY, I ;
KATER, CE .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 32 (1B) :199-204
[5]  
BIGLIERI EG, 1974, CIRC RES, V34, pI183
[6]   THE CHANGING CLINICAL SPECTRUM OF PRIMARY ALDOSTERONISM [J].
BRAVO, EL ;
TARAZI, RC ;
DUSTAN, HP ;
FOUAD, FM ;
TEXTOR, SC ;
GIFFORD, RW ;
VIDT, DG .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (04) :641-651
[7]  
BRAVO EL, 1986, HYPERTENSION, V8, P191
[8]   ANGIOTENSIN-II RECEPTORS AND INVITRO ALDOSTERONE RESPONSES OF ALDOSTERONE-PRODUCING ADENOMAS, ADJACENT NONTUMOROUS TISSUE, AND NORMAL HUMAN ADRENAL GLOMERULOSA [J].
BROWN, G ;
DOUGLAS, J ;
BRAVO, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (04) :718-723
[9]   THE ABSENCE OF LONG-TERM THERAPEUTIC EFFECT OF CALCIUM-CHANNEL BLOCKADE IN THE PRIMARY ALDOSTERONISM OF ADRENAL ADENOMAS [J].
BURSZTYN, M ;
GROSSMAN, E ;
ROSENTHAL, T .
AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (03) :S88-S90
[10]  
FERRISS JB, 1970, LANCET, V2, P995